Literature DB >> 22668639

Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.

Mohamed A Abdelmegeed1, Atrayee Banerjee, Seong-Ho Yoo, Sehwan Jang, Frank J Gonzalez, Byoung-Joon Song.   

Abstract

BACKGROUND & AIMS: Ethanol-inducible cytochrome P450 2E1 (CYP2E1) activity contributes to oxidative stress. However, CYP2E1 may have an important role in the pathogenesis of high-fat mediated non-alcoholic steatohepatitis (NASH). Thus, the role of CYP2E1 in high-fat mediated NASH development was evaluated.
METHODS: Male wild type (WT) and Cyp2e1-null mice were fed a low-fat diet (LFD, 10% energy-derived) or a high-fat diet (HFD, 60% energy-derived) for 10 weeks. Liver histology and tissue homogenates were examined for various parameters of oxidative stress and inflammation.
RESULTS: Liver histology showed that only WT mice fed a HFD developed NASH despite the presence of increased steatosis in both WT and Cyp2e1-null mice fed HFD. Markers of oxidative stress such as elevated CYP2E1 activity and protein amounts, lipid peroxidation, protein carbonylation, nitration, and glycation with increased phospho-JNK were all markedly elevated only in the livers of HFD-fed WT mice. Furthermore, while the levels of inflammation markers osteopontin and F4/80 were higher in HFD-fed WT mice, TNFα and MCP-1 levels were lower compared to the corresponding LFD-fed WT. Finally, only HFD-fed WT mice exhibited increased insulin resistance and impaired glucose tolerance.
CONCLUSIONS: These data suggest that CYP2E1 is critically important in NASH development by promoting oxidative/nitrosative stress, protein modifications, inflammation, and insulin resistance. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668639      PMCID: PMC3445664          DOI: 10.1016/j.jhep.2012.05.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  41 in total

1.  Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet.

Authors:  Y P Yun; J P Casazza; D H Sohn; R L Veech; B J Song
Journal:  Mol Pharmacol       Date:  1992-03       Impact factor: 4.436

2.  Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance.

Authors:  Haihong Zong; Michal Armoni; Chava Harel; Eddy Karnieli; Jeffrey E Pessin
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-20       Impact factor: 4.310

3.  Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.

Authors:  Inmaculada García-Ruiz; Cristina Rodríguez-Juan; Teresa Díaz-Sanjuan; Pilar del Hoyo; Francisco Colina; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

Review 4.  Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.

Authors:  J Aubert; K Begriche; L Knockaert; M A Robin; B Fromenty
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-06-12       Impact factor: 2.947

5.  Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity.

Authors:  Mohamed A Abdelmegeed; Kwan-Hoon Moon; Chi Chen; Frank J Gonzalez; Byoung-Joon Song
Journal:  Biochem Pharmacol       Date:  2009-08-04       Impact factor: 5.858

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

Authors:  Jörn M Schattenberg; Yongjun Wang; Rajat Singh; Raina M Rigoli; Mark J Czaja
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

8.  Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice.

Authors:  Defeng Wu; Arthur Cederbaum
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

Review 9.  Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-03-11

10.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

View more
  99 in total

1.  An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver.

Authors:  Eunsook S Jin; A Dean Sherry; Craig R Malloy
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

Review 2.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

3.  The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease.

Authors:  Kirsten-Berit Linhart; Katharina Glassen; Teresa Peccerella; Rüdiger Waldherr; Heinz Linhart; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

4.  Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity.

Authors:  Suvarthi Das; Ashutosh Kumar; Ratanesh Kumar Seth; Erik J Tokar; Maria B Kadiiska; Michael P Waalkes; Ronald P Mason; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-02-22       Impact factor: 4.219

Review 5.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

6.  Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  J Nutr Biochem       Date:  2016-09-22       Impact factor: 6.048

7.  Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.

Authors:  Kelly E Mercer; Leah Hennings; Neha Sharma; Keith Lai; Mario A Cleves; Rebecca A Wynne; Thomas M Badger; Martin J J Ronis
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-28

8.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

9.  Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury.

Authors:  Mohamed A Abdelmegeed; Sehwan Jang; Atrayee Banerjee; James P Hardwick; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2013-02-27       Impact factor: 7.376

Review 10.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.